HRMY Earnings
Latest Revenue268.9M
Latest Net Income48.2M
| Period | EPS | Revenue | Net Income | Rev YoY | EPS YoY |
|---|
| Q3 2026 | $0.83 | 268.9M | 48.2M | +12.3% | -5.7% |
| Q2 2026 | $1.30 | 261.3M | 75.4M | +30.3% | +88.4% |
| Q1 2026 | $0.56 | 215.4M | 32.5M | +16.6% | -29.1% |
| Q4 2025 | $0.39 | 243.8M | 22.5M | +21.1% | -55.2% |
| Q3 2025 | $0.88 | 239.5M | 50.9M | +28.7% | +8.6% |
| Q2 2025 | $0.69 | 200.5M | 39.8M | +16.0% | +245.0% |
| Q1 2025 | $0.79 | 184.7M | 45.6M | +19.5% | +16.2% |
| Q4 2024 | $0.87 | 201.3M | 49.5M | +19.5% | +89.1% |
| Q3 2024 | $0.81 | 186.0M | 46.1M | — | — |
| Q2 2024 | $0.20 | 172.8M | 11.6M | — | — |
| Q1 2024 | $0.68 | 154.6M | 38.3M | — | — |
| Q4 2023 | $0.46 | 168.4M | 26.6M | — | — |
Harmony Biosciences (HRMY) — Earnings